Pulmonary Hypertension, Right Ventricular Function, and Clinical Outcome in Acute Decompensated Heart Failure

被引:69
|
作者
Aronson, Doron [1 ,2 ]
Darawsha, Wisam [1 ,2 ]
Atamna, Aula [1 ,2 ]
Kaplan, Marielle [2 ,3 ]
Makhoul, Badira F. [2 ,4 ]
Mutlak, Diab [1 ,2 ]
Lessick, Jonathan [1 ,2 ]
Carasso, Sitemy [1 ,2 ]
Reisner, Shimon [1 ,2 ]
Agmon, Yoram [1 ,2 ]
Dragu, Robert [1 ,2 ]
Azzam, Zaher S. [2 ,4 ]
机构
[1] Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel
[3] Rambam Med Ctr, Lab Clin Biochem, IL-31096 Haifa, Israel
[4] Rambam Med Ctr, Dept Internal Med B, IL-31096 Haifa, Israel
关键词
Acute heart failure; prognosis; pulmonary hypertension; right ventricle; PRESERVED EJECTION FRACTION; ARTERY PRESSURE; SYSTOLIC FUNCTION; EUROPEAN-SOCIETY; PROGNOSTIC VALUE; DETERMINANTS; GUIDELINES; ECHOCARDIOGRAPHY; PATHOPHYSIOLOGY; ASSOCIATION;
D O I
10.1016/j.cardfail.2013.08.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary hypertension (PH) and right ventricular (RV) dysfunction have been associated with adverse outcome in patients with chronic heart failure. However, data are lacking in the setting of acute decompensated heart failure (ADHF). We sought to determine prognostic significance of PH in patients with ADBF and its interaction with RV function. Methods: We studied 326 patients with ADHF. Pulmonary artery systolic pressure (PASP) and RV function were determined with the use of Doppler echocardiography, with PH defined as PASP >50 mm Hg. The primary end point was all-cause mortality during 1-year follow-up. Results: PH was present in 139 patients (42.6%) and RV dysfunction in 83 (25.5%). The majority of patients (70%) with RV dysfunction had PH. Compared with patients with normal RV function and without PH, the adjusted hazard ratio (HR) for mortality was 2.41 (95% confidence interval [CI] 1.44-4.03; P = .001) in patients with both RV dysfunction and PH. Patients with normal RV function and PH had an intermediate risk (adjusted HR 1.78, 95% CI 1.11-2.86; P = .016). Notably, patients with RV dysfunction without PH were not at increased risk for 1-year mortality (HR 1.04, 95% CI 0.43-2.41; P = .94). PH and RV function data resulted in a net reclassification improvement of 22.25% (95% CI 7.2%-37.8%; P = .004). Conclusions: PH and RV function provide incremental prognostic information in ADHF. The combination of PH and RV dysfunction is particularly ominous. Thus, the estimation of PASP may be warranted in the standard assessment of ADHF.
引用
收藏
页码:665 / 671
页数:7
相关论文
共 50 条
  • [21] Right ventricular function and its coupling with the pulmonary circulation in acute heart failure
    Barki, M.
    Losito, M.
    Caracciolo, M. M.
    Bandera, F.
    Rovida, M.
    Alfonzetti, E.
    Guazzi, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1218 - 1218
  • [22] Progression Toward Decompensated Right Ventricular Failure in the Ovine Pulmonary Hypertension Model
    Ukita, Rei
    Tumen, Andrew
    Stokes, John W.
    Pinelli, Christopher
    Finnie, Kelsey R.
    Talackine, Jennifer
    Cardwell, Nancy L.
    Wu, W. Kelly
    Patel, Yatrik
    Tsai, Emily J.
    Rosenzweig, Erika B.
    Cook, Keith E.
    Bacchetta, Matthew
    ASAIO JOURNAL, 2022, 68 (02) : E29 - E33
  • [23] A Case of Chronic Pulmonary Embolism Resulting in Pulmonary Hypertension and Decompensated Right Heart Failure
    Hosna, Asma U.
    Miller, Daniel
    Makhoul, Karim
    Noff, Nicole
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [24] Pulmonary circulatory-right ventricular uncoupling in acute decompensated heart failure: a key mediator of congestion
    Losito, M.
    Barki, M.
    Labate, V.
    Giammarresi, A.
    Caracciolo, M.
    Bandera, F.
    Rovida, M.
    Alfonzetti, E.
    Guazzi, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2725 - 2725
  • [25] Epidemiology of Pulmonary Hypertension and Right Ventricular Failure in Left Heart Failure
    Thenappan T.
    Gomberg-Maitland M.
    Current Heart Failure Reports, 2014, 11 (4) : 428 - 435
  • [26] Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models
    Khazanie, Prateeti
    Heizer, Gretchen M.
    Hasselblad, Vic
    Armstrong, Paul W.
    Califf, Robert M.
    Ezekowitz, Justin
    Dickstein, Kenneth
    Levy, Wayne C.
    McMurray, John J. V.
    Metra, Marco
    Tang, W. H. Wilson
    Teerlink, John R.
    Voors, Adriaan A.
    O'Connor, Christopher M.
    Hernandez, Adrian F.
    Starling, Randall
    AMERICAN HEART JOURNAL, 2015, 170 (02) : 290 - U128
  • [27] Reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure
    Aronson, D.
    Eitan, A.
    Dragu, R.
    Burger, A. A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 963 - 963
  • [28] Clinical Significance of Right Ventricular Function in Pulmonary Hypertension
    Murata, Mitsushige
    KEIO JOURNAL OF MEDICINE, 2021, 70 (03): : 60 - 67
  • [29] Recognizing Pulmonary Hypertension and Right Ventricular Dysfunction in Heart Failure
    Lala, Anuradha
    Pinney, Sean P.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2016, 58 (04) : 416 - 424
  • [30] Sildenafil in acutely decompensated right heart failure secondary to pulmonary arterial hypertension
    Sood, N
    Whitby, G
    CHEST, 2005, 128 (04) : 174S - 175S